Translate this page into:
Placental histomorphology in unexplained foetal loss with thrombophilia
Reprint requests: Dr Kanjaksha Ghosh, Director, National Institute of Immunohaematology (ICMR), KEM Hospital Parel, Mumbai 400 012, India e-mail: kanjakshaghosh@hotmail.com
-
Received: ,
Abstract
Background & objectives:
Acquired and genetic thrombotic conditions, both organ and non organ specific, are associated with increased foetal wastage. This study was carried out to examine the placenta from women with abnormal pregnancies and a history of unexplained foetal loss, and to associate with maternal thrombophilia status.
Methods:
Placentas from eight women with history of unexplained foetal loss were analyzed for histopathological characteristics. All the women were simultaneously screened for the common acquired and genetic thrombophilia markers i.e., lupus anticoagulants (LA), IgG / IgM antibodies for anticardiolipin (ACA), β2 glycoprotein 1 (β2GPI) and annexin V, protein C (PC), protein S (PS), antithrombin III (AT III), factor V Leiden (FVL) mutation, prothrombin (PT) gene G20210A, methylene tetrahydrofolate reductase (MTHFR) C 677T, endothelial protein C receptor (EPCR) 23 bp insertion and plasminogen activator inhibitor (PAI-1 4G/5G) polymorphisms.
Results:
Six of eight women were positive for one or more thrombophilia markers. The placenta in all the cases except one, showed the characteristic features of infarct fibrin deposition and calcification. Among two women who were negative for thrombophilia, one showed clear evidence of thrombus in the placental sections while the other did not show any characteristic infarcts in the placental sections.
Interpretation & conclusion:
Our findings showed that the histopathological examination of the placentas confirmed thrombophilia as the aetiological cause of thrombosis in 6 of the 8 women. The presence of thrombus in a negative thrombophilia woman suggests yet unidentified thrombophilia markers or probably non-haemostatic factors causing thrombosis.
